Medicine Delivery Complaints Rise in Balochistan
Here’s a breakdown of the key data from the provided text, focusing on the core issue and supporting details:
Main Issue:
Patients in Colombia are facing significant difficulties accessing necessary prescription medications through their new EPS (health insurance providers) due to shortages. This is disrupting treatments and forcing patients to purchase medications out-of-pocket.
Supporting Details:
Specific Examples:
carlos Martínez received only 2 out of 5 prescribed medications for his wife.
Luis Hernández has been waiting for 5 medications for three months, and is only being given cheaper alternatives.He spends approximately 200,000 pesos (Colombian currency) to buy the missing medications.
Ronaldo Escobar struggles to obtain his grandmother’s arthritis/osteoarthritis medications, often being told they are discontinued.
Impact on Patients:
Disrupted treatments.
Financial burden of purchasing medications privately.
Concern about the effectiveness of treatment if medications are unavailable.
* Government Intervention: The Superintendence of Industry and Commerce (SIC) is involved in negotiating medicine prices with laboratories and the 9 EPS under government intervention. (The text ends mid-sentence, so the full context of this intervention is unclear).In essence, the article highlights a growing healthcare crisis in Colombia where patients are unable to reliably access the medications they need, despite being covered by health insurance.